Fetzima

Generic name: Levomilnacipran
Drug class: Serotonin-norepinephrine reuptake inhibitors

Usage of Fetzima

Fetzima is a selective serotonin and norepinephrine reuptake inhibitor antidepressant (SNRI). Levomilnacipran affects chemicals in the brain that may be unbalanced in people with depression.

Fetzima extended release capsules are used to treat major depressive disorder.

A similar medicine called milnacipran (Savella) is used to treat a chronic pain disorder called fibromyalgia. Fetzima should not be used to treat fibromyalgia.

Fetzima side effects

Get emergency medical help if you have signs of an allergic reaction to Fetzima: skin rash or hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Tell your doctor right away if you have new or sudden changes in mood or behavior, including new or worse depression or anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, more active or talkative, or have thoughts about suicide or hurting yourself.

Call your doctor at once if you have:

blurred vision, tunnel vision, eye pain or swelling, eye redness;

painful or difficult urination;

easy bruising, unusual bleeding, purple or red spots under your skin;

pounding heartbeats or fluttering in your chest;

seizure (convulsions);

manic episodes - racing thoughts, increased energy, decreased need for sleep, risk-taking behavior, being agitated or talkative; or

low sodium level - headache, confusion, slurred speech, severe weakness, vomiting, loss of coordination, feeling unsteady.

Serious side effects may be more likely in older adults.

Seek medical attention right away if you have symptoms of serotonin syndrome, such as: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.

Common Fetzima side effects may include:

nausea, vomiting, constipation;

irregular heartbeats;

sweating; or

decreased sex drive, impotence, or difficulty having an orgasm.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Fetzima

You should not use Fetzima if you are allergic to levomilnacipran or milnacipran (Savella).

Do not use Fetzima within 7 days before or 14 days after you have taken an MAO inhibitor. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, tranylcypromine, and others.

Tell your doctor if you also use stimulant medicine, opioid medicine, herbal products, or medicine for depression, mental illness, Parkinson's disease, migraine headaches, serious infections, or prevention of nausea and vomiting. An interaction with levomilnacipran could cause a serious condition called serotonin syndrome.

To make sure Fetzima is safe for you, tell your doctor if you have ever had:

glaucoma;

heart problems, high blood pressure;

a stroke;

bleeding problems;

urination problems;

sexual problems;

kidney disease;

a seizure;

low levels of sodium in your blood;

bipolar disorder (manic depression);

if there is a history of depression, manic behavior, or suicide in your family; or

if you drink alcohol.

People with depression or mental illness may have thoughts about suicide. Some young people may have increased suicidal thoughts when first starting a medicine to treat depression. Stay alert to changes in your mood or symptoms. Your family or caregivers should also watch for sudden changes in your behavior.

Ask your doctor about taking this medicine if you are pregnant. Taking an SNRI antidepressant during late pregnancy could increase your risk of excessive bleeding just after you give birth, and may cause serious medical complications in the baby. However, you may have a relapse of depression if you stop taking your antidepressant. Tell your doctor right away if you become pregnant. Do not start or stop taking this medicine without your doctor's advice.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of levomilnacipran on the baby.

If you are breastfeeding while taking Fetzima, tell your doctor if your baby is agitated or irritable and has feeding problems or trouble gaining weight.

Fetzima is not approved for use by anyone younger than 18 years old.

Relate drugs

How to use Fetzima

Usual Adult Dose for Depression:

Initial dose: 20 mg orally once a day for 2 days, then increase to 40 mg orally once a day Maintenance dose: 40 to 120 mg orally once a day Maximum dose: 120 mg/day Comments: -The dose may be increased in increments of 40 mg at intervals of 2 or more days based on tolerability and efficacy. -Efficacy was established in trials lasting 5 weeks. Use: Treatment of Major Depressive Disorder (MDD)

Warnings

You should not use Fetzima if you have untreated or uncontrolled narrow-angle glaucoma.

Do not use Fetzima within 7 days before or 14 days after you have taken an MAO inhibitor, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, Selegiline, and tranylcypromine.

People with depression or mental illness may have thoughts about suicide. Some young people may have increased suicidal thoughts when first starting a medicine to treat depression. Tell your doctor right away if you have any sudden changes in mood or behavior, or thoughts about suicide.

Do not stop using Fetzima without first asking your doctor.

Fetzima is not approved for use by anyone younger than 18 years old.

What other drugs will affect Fetzima

Using Fetzima with other drugs that make you drowsy can worsen this effect. Ask your doctor before using opioid medication, a sleeping pill, a muscle relaxer, or medicine for anxiety or seizures.

Tell your doctor about all your other medicines, especially:

any other antidepressant;

sibutramine;

St. John's wort;

tryptophan (sometimes called L-tryptophan);

a diuretic or "water pill";

a blood thinner (warfarin, Coumadin, Jantoven);

diet pills, stimulants, or medicine to treat attention deficit hyperactivity disorder (ADHD) such as Adderall or Ritalin;

pain medication - fentanyl, tramadol;

medicine to treat anxiety, mood disorders, thought disorders, or mental illness - Buspirone, lithium, and many others; or

migraine headache medicine - sumatriptan, rizatriptan, zolmitriptan, and others.

This list is not complete. Other drugs may interact with levomilnacipran, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.